179 related articles for article (PubMed ID: 33496367)
21. Comprehensive Immune Profiling Reveals CD56
Dutt TS; LaVergne SM; Webb TL; Baxter BA; Stromberg S; McFann K; Berry K; Tipton M; Alnachoukati O; Zier L; Ebel G; Dunn J; Henao-Tamayo M; Ryan EP
J Immunol; 2022 Feb; 208(3):685-696. PubMed ID: 34987111
[TBL] [Abstract][Full Text] [Related]
22. Increased sCD163 and sCD14 Plasmatic Levels and Depletion of Peripheral Blood Pro-Inflammatory Monocytes, Myeloid and Plasmacytoid Dendritic Cells in Patients With Severe COVID-19 Pneumonia.
Zingaropoli MA; Nijhawan P; Carraro A; Pasculli P; Zuccalà P; Perri V; Marocco R; Kertusha B; Siccardi G; Del Borgo C; Curtolo A; Ajassa C; Iannetta M; Ciardi MR; Mastroianni CM; Lichtner M
Front Immunol; 2021; 12():627548. PubMed ID: 33777012
[TBL] [Abstract][Full Text] [Related]
23. Blood Interferon-α Levels and Severity, Outcomes, and Inflammatory Profiles in Hospitalized COVID-19 Patients.
Contoli M; Papi A; Tomassetti L; Rizzo P; Vieceli Dalla Sega F; Fortini F; Torsani F; Morandi L; Ronzoni L; Zucchetti O; Pavasini R; Fogagnolo A; Volta CA; Bartlett NW; Johnston SL; Spadaro S; Campo G
Front Immunol; 2021; 12():648004. PubMed ID: 33767713
[No Abstract] [Full Text] [Related]
24. Circulating endothelial progenitors are increased in COVID-19 patients and correlate with SARS-CoV-2 RNA in severe cases.
Mancuso P; Gidaro A; Gregato G; Raveane A; Cremonesi P; Quarna J; Caccia S; Gusso L; Rusconi S; Giacomelli A; Cogliati C; Bertolini F
J Thromb Haemost; 2020 Oct; 18(10):2744-2750. PubMed ID: 32762140
[TBL] [Abstract][Full Text] [Related]
25. Impaired Cytotoxic Response in PBMCs From Patients With COVID-19 Admitted to the ICU: Biomarkers to Predict Disease Severity.
Vigón L; Fuertes D; García-Pérez J; Torres M; Rodríguez-Mora S; Mateos E; Corona M; Saez-Marín AJ; Malo R; Navarro C; Murciano-Antón MA; Cervero M; Alcamí J; García-Gutiérrez V; Planelles V; López-Huertas MR; Coiras M
Front Immunol; 2021; 12():665329. PubMed ID: 34122423
[TBL] [Abstract][Full Text] [Related]
26. Eight-color panel for immune phenotype monitoring by flow cytometry.
Cardoso CC; Santos-Silva MC
J Immunol Methods; 2019 May; 468():40-48. PubMed ID: 30914269
[TBL] [Abstract][Full Text] [Related]
27. A Granulocytic Signature Identifies COVID-19 and Its Severity.
Vitte J; Diallo AB; Boumaza A; Lopez A; Michel M; Allardet-Servent J; Mezouar S; Sereme Y; Busnel JM; Miloud T; Malergue F; Morange PE; Halfon P; Olive D; Leone M; Mege JL
J Infect Dis; 2020 Nov; 222(12):1985-1996. PubMed ID: 32941618
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic and analytical performance evaluation of ten commercial assays for detecting SARS-CoV-2 humoral immune response.
Mylemans M; Van Honacker E; Nevejan L; Van Den Bremt S; Hofman L; Poels J; Cattoir L; Boel A; Van Hoovels L
J Immunol Methods; 2021 Jun; 493():113043. PubMed ID: 33773989
[TBL] [Abstract][Full Text] [Related]
29. mRNA vaccine-induced T cells respond identically to SARS-CoV-2 variants of concern but differ in longevity and homing properties depending on prior infection status.
Neidleman J; Luo X; McGregor M; Xie G; Murray V; Greene WC; Lee SA; Roan NR
Elife; 2021 Oct; 10():. PubMed ID: 34636722
[TBL] [Abstract][Full Text] [Related]
30. Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID-19 Patients.
Luchsinger LL; Ransegnola BP; Jin DK; Muecksch F; Weisblum Y; Bao W; George PJ; Rodriguez M; Tricoche N; Schmidt F; Gao C; Jawahar S; Pal M; Schnall E; Zhang H; Strauss D; Yazdanbakhsh K; Hillyer CD; Bieniasz PD; Hatziioannou T
J Clin Microbiol; 2020 Nov; 58(12):. PubMed ID: 32917729
[TBL] [Abstract][Full Text] [Related]
31. Cytometry of Mass for Murine Immunoprofiling.
Chandra V; McAllister F; Burks JK
Methods Mol Biol; 2022; 2435():129-137. PubMed ID: 34993943
[TBL] [Abstract][Full Text] [Related]
32. CyTOF: An Emerging Technology for Single-Cell Proteomics in the Mouse.
Tracey LJ; An Y; Justice MJ
Curr Protoc; 2021 Apr; 1(4):e118. PubMed ID: 33887117
[TBL] [Abstract][Full Text] [Related]
33. Phenotyping of tumor infiltrating immune cells using mass-cytometry (CyTOF).
Maby P; Corneau A; Galon J
Methods Enzymol; 2020; 632():339-368. PubMed ID: 32000904
[TBL] [Abstract][Full Text] [Related]
34. Optimized protocols for isolation, fixation, and flow cytometric characterization of leukocytes in ischemic hearts.
Covarrubias R; Ismahil MA; Rokosh G; Hamid T; Accornero F; Singh H; Gumina RJ; Prabhu SD; Bansal SS
Am J Physiol Heart Circ Physiol; 2019 Sep; 317(3):H658-H666. PubMed ID: 31373510
[TBL] [Abstract][Full Text] [Related]
35. Persistence assessment of SARS-CoV-2-specific IgG antibody in recovered COVID-19 individuals and its association with clinical symptoms and disease severity: A prospective longitudinal cohort study.
Moradi G; Mohamadi Bolbanabad A; Ahmadi S; Aghaei A; Bahrami F; Veysi A; Nasiri Kalmarzi R; Shokri A; Ghaderi E; Mohsenpour B; Mohammadi A
Int Immunopharmacol; 2021 Sep; 98():107893. PubMed ID: 34174700
[TBL] [Abstract][Full Text] [Related]
36. Stabilization of Human Whole Blood Samples for Multicenter and Retrospective Immunophenotyping Studies.
Rybakowska P; Burbano C; Van Gassen S; Varela N; Aguilar-Quesada R; Saeys Y; Alarcón-Riquelme ME; Marañón C
Cytometry A; 2021 May; 99(5):524-537. PubMed ID: 33070416
[TBL] [Abstract][Full Text] [Related]
37. IgG Antibodies, SARS-CoV-2 Load, and Prognostic Indicators in Patients with Severe and Mild COVID-19 in Japan.
Kashiwagi K; Maeda T; Yoshizawa S; Sato T; Aoki K; Ishii Y; Tateda K
J Nippon Med Sch; 2021 Sep; 88(4):380-383. PubMed ID: 33250476
[TBL] [Abstract][Full Text] [Related]
38. Analysis of Serological Biomarkers of SARS-CoV-2 Infection in Convalescent Samples From Severe, Moderate and Mild COVID-19 Cases.
Castillo-Olivares J; Wells DA; Ferrari M; Chan ACY; Smith P; Nadesalingam A; Paloniemi M; Carnell GW; Ohlendorf L; Cantoni D; Mayora-Neto M; Palmer P; Tonks P; Temperton NJ; Peterhoff D; Neckermann P; Wagner R; Doffinger R; Kempster S; Otter AD; Semper A; Brooks T; Albecka A; James LC; Page M; Schwaeble W; Baxendale H; Heeney JL
Front Immunol; 2021; 12():748291. PubMed ID: 34867975
[TBL] [Abstract][Full Text] [Related]
39. Monocyte CD169 expression in COVID-19 patients upon intensive care unit admission.
Ortillon M; Coudereau R; Cour M; Rimmelé T; Godignon M; Gossez M; Yonis H; Argaud L; Lukaszewicz AC; Venet F; Monneret G
Cytometry A; 2021 May; 99(5):466-471. PubMed ID: 33547747
[TBL] [Abstract][Full Text] [Related]
40. Single-Dilution COVID-19 Antibody Test with Qualitative and Quantitative Readouts.
Bortz RH; Florez C; Laudermilch E; Wirchnianski AS; Lasso G; Malonis RJ; Georgiev GI; Vergnolle O; Herrera NG; Morano NC; Campbell ST; Orner EP; Mengotto A; Dieterle ME; Fels JM; Haslwanter D; Jangra RK; Celikgil A; Kimmel D; Lee JH; Mariano MC; Nakouzi A; Quiroz J; Rivera J; Szymczak WA; Tong K; Barnhill J; Forsell MNE; Ahlm C; Stein DT; Pirofski LA; Goldstein DY; Garforth SJ; Almo SC; Daily JP; Prystowsky MB; Faix JD; Fox AS; Weiss LM; Lai JR; Chandran K
mSphere; 2021 Apr; 6(2):. PubMed ID: 33883259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
